PBX4 antisense RNA 1 (PBX4-AS1)

PBX4 antisense RNA 1 (PBX4-AS1) is presumed to be a long non-coding antisense RNA transcribed from the strand opposite the PBX4 gene locus. As of now, there is no published experimental evidence or structured record specifically for PBX4-AS1. It does not appear as a well-characterized or therapeutically validated molecule in major genomic or target databases, nor in current research literature. The molecule may represent an annotated transcript or theoretical lncRNA based on bioinformatic prediction rather than primary research validation, lacking peer-reviewed validation. Therefore, PBX4-AS1 is not considered a therapeutic target. PBX4 itself is a validated transcription factor implicated in various cancers, and antisense lncRNAs, in general, can regulate sense gene expression or chromatin state; however, PBX4-AS1's specific function, biological activity, disease relevance, or its role as a therapeutic target are not characterized. No drugs are known to interact with PBX4-AS1, no mechanism of action is established for PBX4-AS1-targeting drugs, and it is not established as a biomarker nor are there any safety concerns reported. PBX4-AS1 should be flagged as an uncharacterized transcript requiring further validation before being considered an actionable target or included in therapeutic decision-making.